| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |